Training data set | Validation data set | Variable description |
1 357 989 | 1 356 245 | Sample size |
4.9% | 4.9% | Per cent with a death date listed (2015 through first quarter of 2016) |
29.5% | 29.5% | Per cent with six or more months of HMO in 2014 |
16.7% | 16.7% | Per cent with six or more months of state buy in for 2014 (duals) |
1.56 | 1.55 | Average Charlson score per person |
0.6% | 0.6% | Per cent of people with a hospice claim in the last 120 days of 2014 |
Annualised utilisation rates per 1000 | ||
250.3 | 252.0 | Ambulatory/surgery visits |
249.9 | 251.6 | Ancillary visits |
1456.5 | 1452.3 | Diagnostic services visits |
1318.3 | 1316.0 | Emergency department visits |
318.0 | 315.9 | Inpatient admissions |
221.0 | 220.4 | Non-acute visits |
7749.5 | 7746.4 | Outpatient visits |
Demographics | ||
54.3% | 54.5% | Per cent Female |
45.7% | 45.5% | Per cent Male |
87.1% | 87.0% | Per cent age 60 and over |
69.8 | 69.9 | Average age |
Charlson conditions (percentage of population in data set) | ||
2.9% | 2.9% | Myocardial infarction |
7.3% | 7.3% | CHF |
9.4% | 9.4% | PVD |
8.5% | 8.5% | Cerebrovascular disease |
2.6% | 2.6% | Dementia |
14.1% | 14.1% | Chronic pulmonary disease |
2.7% | 2.7% | Connective tissue disease-rheumatic disease |
0.9% | 0.9% | PUD |
3.1% | 3.1% | Mild liver disease |
18.4% | 18.4% | Diabetes without complications |
6.1% | 6.1% | Diabetes with complications |
1.0% | 1.1% | Paraplegia and hemiplegia |
7.7% | 7.6% | Renal disease |
7.8% | 7.7% | Cancer |
0.3% | 0.3% | Moderate or severe liver disease |
0.9% | 0.9% | Metastatic carcinoma |
0.3% | 0.3% | AIDS/HIV |
CHF, congestive heart failure; HMO, health maintenance organisation; PUD, peptic ulcer disease; PVD, peripheral vascular disease.